Decision Diagnostics' Pharma Tech Division Schedules Large Order Shipments for Its Popular GenStrip Test Strip Recent Court Rulings and Changes in Medicare Reimbursement Practice Enhancing GenStrip Sales LOS ANGELES, CA -- (Marketwired) -- 10/01/13 -- Decision Diagnostics Corp. (OTCBB: DECN), the exclusive worldwide sales, service and regulatory processes agent for the popular Shasta GenStrip(TM), the unique Green Glucose Test Strip, specifically designed to work with the Johnson & Johnson's (NYSE: JNJ) LifeScan Ultra family of glucose testing meters, today announced that its Pharma Tech Solutions subsidiary has scheduled for shipments large box quantities of GenStrip for immediate delivery to its distributors as partial fulfillment of current sales orders. Keith Berman, Principal Executive Officer of Decision Diagnostics, commented, "Beginning in July 2013 Medicare changed its reimbursement practice. These changes have proven to be an unexpected boom for our business." DECN is a leading provider of prescription and non-prescription diagnostics, home testing products for the chronically ill and a premier developer of revolutionary cell phone centric e-health products and technologies. DECN's FDA cleared Shasta GenStrip(TM) product was first introduced to the market in late 2012 as a lower cost (50%) alternative for user/owners of Johnson and Johnson LifeScan OneTouch(R) Ultra(R), Ultra2(R) and Ultra Mini(R) glucose meters. Mr. Berman concluded, "In August and September 2013 we received several favorable court rulings and the analyses of these rulings from the media added to the positive outlook for GenStrip sales. The product is being looked at by all of the large retailers and is already a hit with the independent distributors. Initially we will take delivery of over 60,000 boxes of GenStrip to begin fulfillment of existing orders." The company also reminds shareholders and all interested parties that it continues to air its new commercial video titled "GenStrip: A Patchwork of Life." The company plans on releasing a media schedule in the coming days. In the meantime, the extremely popular video is available for viewing at: http://shastagenstrip.com/shasta_ad.html or http://youtu.be/zzBuHxb-rlM. Forward-Looking Statements: This release contains forward-looking statements about our business or financial condition that reflect our assumptions and beliefs based on information currently available. We can give no assurance that the expectations indicated by such forward-looking statements will be realized. There may be other risks and circumstances that we are unable to predict. When used in this release, words such as "believes," "expects," "forecasts," "intends," "projects," "plans," "anticipates," "estimates," "will" and similar expressions are intended to identify forward-looking statements, although there may be certain statements not accompanied by such expressions. For further information about Shasta GenStrip, please visit the company's Web Sites: http://www.decisiondiagnostics.com or http://www.shastagenstrip.com. GenStrip(TM) test strips are a product of Shasta Technologies, LLC and are not manufactured, distributed, endorsed, or approved by nor associated with LifeScan(R), Inc. a Johnson & Johnson(R) Company, manufacturers and distributors of the OneTouch(R) Ultra(R) Family of Meters and OneTouch(R) Ultra(R) test strips. Contact: Decision Diagnostics Corp. Keith Berman (805) 446-2973 email@example.com
Decision Diagnostics' Pharma Tech Division Schedules Large Order Shipments for Its Popular GenStrip Test Strip
Press spacebar to pause and continue. Press esc to stop.